python said:
the way the text reads, it looks like a meeting between the technical people, not the policy makers, from the various wada labs. there is a well known divergence of opinions there.
the surge and of sudden acquittals by the several national feds and the 1st unprecedented wada refusal to appeal to cas ovcharov's clen case, make for the news i predicted many months ago.
howman is on record that wada will not consider any changes to clenbuterol regulations before the cas ruling on contador.
Ovcharov's case wasn't appealed because of economic reasons - WADA has a limited budget and must pick its fights carefully. It had nothing to do with the fact that WADA thinks he was innocent and agreed with the federation's decision. WADA doesn't appeal the small fish (your use of the word "unprecedented" is simply wrong as WADA declines to appeal dozens of cases every year that they disagree with) or where the use of clenbuterol had negligible performance gain to a particular sport (table tennis in the case of ocharov) .
In cycling for the Tour de France, it's a different ballgame. Clenbuterol has
significant performance enhancing effect that directly translates into large financial gains whereas in ping pong, clen has very little effect even if the guy took it intentionally (does a ping pong player really need to lose that extra pound before the big match?)
You people really don't have a clue on why WADA does and doesn't appeal certain cases, do you? But I love how you talk like WADA's actions confirm what is really your
misapprehension.
Sometimes I feel like I'm herding sheep in here.